Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.